🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute myeloid leukemia (AML) is one of the most common hematologic malignan...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-04-01
Trial ID
NCT07500753
Treatments Being Tested
This is a Phase Ib/II, open-label, multi-center study evaluating the safety...
Status
Unknown
Location
UCLA Medical cetner Division of Hematology
Start Date
2021-07-30
Trial ID
NCT04964518
Treatments Being Tested
This study evaluates the efficacy and safety of maintenance therapy with li...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-10
Trial ID
NCT07686965
Treatments Being Tested
To find the recommended doses of lisaftoclax and olverembatinib that can be...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-08-06
Trial ID
NCT06401603
Treatments Being Tested
A global, multicenter, randomized, double-blind, placebo-controlled, phase ...
Status
Recruiting
Location
Hematology Hospital of the Chinese Academy of Medical Sciences
Start Date
2024-06-11
Trial ID
NCT06389292
Treatments Being Tested
A global multicenter, randomized, double-blind, placebo-controlled, pivotal...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2025-01-22
Trial ID
NCT06641414
Treatments Being Tested
The purpose of this study is to assess the safety, pharmacokinetic profile ...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2020-09-28
Trial ID
NCT04501120
To study the optimal therapeutic strategies for salvage treatment of refrac...
Status
Recruiting
Location
Blood Hospital
Start Date
2024-02-22
Trial ID
NCT06265545
This is a phase II/III, multicenter, randomized, three-arm, open-label, par...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Start Date
2026-03-01
Trial ID
NCT07651163
This is a phase II/III, multicenter, randomized, three-arm, open-label, par...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Start Date
2026-03-01
Trial ID
NCT07651176